A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).

AIMS/HYPOTHESIS: The aim of this study was to develop a simulation model for type 2 diabetes that can be used to estimate the likely occurrence of major diabetes-related complications over a lifetime, in order to calculate health economic outcomes such as quality-adjusted life expectancy. METHODS:...

Detaylı Bibliyografya
Asıl Yazarlar:	Clarke, P, Gray, A, Briggs, A, Farmer, A, Fenn, P, Stevens, R, Matthews, DR, Stratton, I, Holman, R
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2004

Benzer Materyaller

UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.
Yazar:: Hayes, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

UKPDS Outcomes Model 2: A new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year united kingdom prospective diabetes Study: UKPDS 82
Yazar:: Hayes, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90)
Yazar:: Leal, J, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
Yazar:: Kohner, E, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).
Yazar:: Stevens, R, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).
Yazar:: Clarke, P, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
Yazar:: Matthews, DR, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).
Yazar:: Alva, M, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Ethnic differences in diabetic nephropathy - The UKPDS
Yazar:: Stevens, R, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Life-expectancy projection by modelling and computer simulation (UKPDS 46).
Yazar:: Stevens, R, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72).
Yazar:: Clarke, P, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Risk factors for neuropathy in UKPDS
Yazar:: Stratton, I, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

UKPDS58--modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes.
Yazar:: Stevens, R, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).
Yazar:: Gray, A, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Temporal validation of the UKPDS outcomes model using 10-year posttrial monitoring data.
Yazar:: Leal, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29.
Yazar:: Davis, T, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
Yazar:: Holman, R, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
Yazar:: Adler, A, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
Yazar:: Cull, C, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.
Yazar:: Turner, R, ve diğerleri
Baskı/Yayın Bilgisi: (1991)

Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63).
Yazar:: Gray, A, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

The natural history of diabetes-related complications: the UKPDS experience. United Kingdom Prospective Diabetes Study.
Yazar:: Matthews, DR
Baskı/Yayın Bilgisi: (1999)

The natural history of diabetes-related complications: the UKPDS experience. United Kingdom Prospective Diabetes Study.
Yazar:: Matthews, DR
Baskı/Yayın Bilgisi: (1999)

Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
Yazar:: Clarke, P, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)
Yazar:: Turner, R, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Forecasting coronary case fatality in type 2 diabetes: a UKPDS Risk Engine equation
Yazar:: Stevens, R, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Estimating cardiovascular risk and all-cause mortality in individuals with type 2 diabetes using the UKPDS Outcomes Model
Yazar:: Coleman, RL, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
Yazar:: Stevens, R, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation
Yazar:: Coleman, R, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.
Yazar:: Gray, A, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.
Yazar:: Gray, A, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

UKPDS: what was the question? UK Prospective Diabetes Study.
Yazar:: Turner, R, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).
Yazar:: Adler, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
Yazar:: Matthews, DR, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
Yazar:: Horton, V, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

UKPDS: Plasma leptin, obesity and plasma insulin in type 2 diabetic subjects
Yazar:: Widjaja, A, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Metformin as first choice in oral diabetes treatment: the UKPDS experience.
Yazar:: Holman, R
Baskı/Yayın Bilgisi: (2007)

Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group.
Yazar:: Kohner, E, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.
Yazar:: Kothari, V, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62).
Yazar:: Clarke, P, ve diğerleri
Baskı/Yayın Bilgisi: (2002)